MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • MDS Virtual Congress 2020

    Assessing the screening performance of three abbreviated smell tests in Parkinson’s disease

    G. Goodwin, H. Li, A. Ismail, H. Azevedo, G. Giovannoni, A. Schrag, A. Lees, J. Cuzick, J. Bestwick, S. Auger, A. Noyce (London, United Kingdom)

    Objective: We aimed to: a) determine the effectiveness of two shortened six-item ‘scratch-and-sniff’ smell tests and an alternative novel alginate capsule scent delivery system in…
  • MDS Virtual Congress 2020

    Improving estimation of Parkinson’s disease risk – enhancing the PREDICT-PD algorithm

    J. Bestwick, S. Auger, D. Grosset, S. Kanavou, G. Giovannoni, A. Lees, J. Cuzick, C. Simonet, R. Rees, D. Rack, M. Jitlal, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To develop and test an enhanced algorithm for the prediction of Parkinson’s disease (PD) risk. Background: The PREDICT-PD algorithm estimates risk of PD using…
  • MDS Virtual Congress 2020

    Hyposmia as a biomarker in patients with Parkinson’s disease and atypical Parkinsonism

    S. Kumaran, A. Ankeeta, S. Chaudhary, P. Bhat, V. Goyal (New Delhi, India)

    Objective: To investigate neural correlates associated with olfactory dysfunction using fMRI and EEG in Parkinsonism. Background: Patients with Parkinsonism experience non-motor symptoms during the onset…
  • MDS Virtual Congress 2020

    The role of dopamine mis-metabolism in preclinical Parkinson’s disease olfactory deficits

    L. Beauchamp, L. Vella, A. Bush, K. Barnham (Melbourne, Australia)

    Objective: To gain an understanding of the underlying pathological mechanisms of Parkinson’s disease (PD)-related hyposmia using post-mortem human olfactory bulbs and an in vivo model…
  • MDS Virtual Congress 2020

    Difference in olfactory impairment between tremor dominant and akinetic rigid dominant Parkinson’s disease patients

    P. Solla, C. Masala, P. Raffaella, S. Dagostino, T. Ercoli, G. Defazio (Monserrato, Italy)

    Objective: To investigate difference in olfactory impairment between tremor dominant (TD) and akinetic rigid dominant (ARD) Parkinson’s disease patients. Background: PD can be classified in…
  • 2019 International Congress

    Specific chemosensory pattern in Parkinson’s disease

    C. Tremblay, R. Emrich, A. Cavazzana, L. Klingelhoefer, M. Brandt, T. Hummel, A. Haehner, J. Frasnelli (Trois-Rivières, QC, Canada)

    Objective: Our objective was to investigate the trigeminal pathway by measuring intranasal and central electrophysiological recordings in response to a specific trigeminal stimulus in patients…
  • 2019 International Congress

    Characterizing olfactory impairment in patients with Parkinson’s disease and related disorders

    Y. Watanabe, K. Suzuki (Mibu, Shimotsuga, Tochigi, Japan)

    Objective: To characterize olfactory impairment in Parkinson’s disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). Background: In the previous study, we found…
  • 2019 International Congress

    Retronasal olfactory function in Parkinson’s disease

    E. Aubry-Lafontaine, C. Tremblay, P. Durand-Martel, N. Dupré, J. Frasnelli (Trois-Rivières, QC, Canada)

    Objective: The objective of this study was to compare orthonasal and retronasal olfactory function in PD patients and compare them to NPOD participants and to…
  • 2019 International Congress

    Non motor symptoms Parkinson’s disease

    N. Bagdanova, Z. Zuleiha (Kazan, Russian Federation)

    Objective: 1.To identify the representation and prevalence of non-motor symptoms of PD in the premotor and early motor stages Background: During the period 2016-2018 104 people were…
  • 2019 International Congress

    Olfactory Hallucinations as a Non-motor sign of Parkinson’s disease- a cross sectional study

    S. Chandra, M. Schiess, R. Mehanna (Houston, TX, USA)

    Objective: To describe the prevalence and characteristics of Olfactory Hallucinations (OlfH) in patients with Parkinson’s Disease (PD) in a tertiary movement clinic. Background: Hallucinations are…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley